Molecular Biomarker-Based Chemotherapy and Targeted Therapy for Glioma

Xin Zhang(Sichuan Cancer Hospital), Nan Zhou(Sichuan University), Yu Yao(Qinghai University)

Experts' Perspectives on Medical Advances.

January 1, 2024

10.1007/978-981-99-0123-4_9

Cited by 0

Related Papers

CGCG clinical practice guidelines for the management of adult diffuse gliomas

|Cancer Letters|2016|650

Clinical practice guidelines for the management of adult diffuse gliomas

|Cancer Letters|2020|482

Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis

|The Lancet Oncology|2016|374

Temozolomide-associated hypermutation in gliomas

|Neuro-Oncology|2018|227

Adult IDH wild-type lower-grade gliomas should be further stratified

|Neuro-Oncology|2017|222